Evidence map›Paper›PMID 24492321›Full record

ReviewNature reviews. Nephrology2014

Noncardiovascular mortality in CKD: an epidemiological perspective.

Dinanda J de Jager, Marc G Vervloet, Friedo W Dekker

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Nephrology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Outcomes of ICDs and CRTs in patients with chronic kidney disease: a meta-analysis of 21,000 patients.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2018
    Pooled it
  4. Pooled it
  5. Review
  6. Article
  7. Article
  8. Inflammatory and Cardiovascular Events in CKD: The Multi-Ethnic Study of Atherosclerosis (MESA).American journal of kidney diseases : the official journal of the National Kidney Foundation · 2025
    Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Kidney Function Measures and Mortality: A Mendelian Randomization Study.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Chronic Kidney Disease and Cancer: Inter-Relationships and Mechanisms.Frontiers in cell and developmental biology · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Dinanda J de JagerDepartment of Clinical Epidemiology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, Netherlands.
Marc G VervloetDepartment of Nephrology, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, Netherlands.
Friedo W DekkerDepartment of Clinical Epidemiology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with chronic kidney disease (CKD) have increased risk of all-cause mortality; the elevated cardiovascular mortality in patients with end-stage renal disease is particularly well documented. Lately, the increased noncardiovascular mortality in these patients has gained particular attention. In this article, both cardiovascular and noncardiovascular mortality in CKD are discussed, with specific attention paid to studies that provide details of noncardiovascular causes of death. Examples are provided of several cardiovascular risk factors that also seem to be associated with noncardiovascular mortality, including levels of fetuin-A, troponin T, and C-reactive protein, as well as vitamin D deficiency and proteinuria. Potential pathophysiological mechanisms (such as inflammatory reactions and the uraemic milieu) that might explain the increased cardiovascular and noncardiovascular mortality in CKD are also discussed. Future research should not only focus on preventing cardiovascular mortality, but also on studying noncardiovascular mortality and the potential link between causal pathways of cardiovascular mortality and noncardiovascular mortality in CKD.

Indexed as

Adultalpha-2-HS-GlycoproteinCardiovascular DiseasesC-Reactive ProteinHumansMaleNeoplasmsProteinuriaRenal Insufficiency, ChronicRisk FactorsTroponin TVitamin D Deficiencyalpha-2-HS-GlycoproteinC-Reactive ProteinTroponin T

Identifiers

PMID24492321

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.